Labile iron in parenteral iron formulations: a quantitative and comparative study

Abstract

Approximately 2-6% of total iron in commonly used IV iron compounds is available for in vitro iron donation to Tf. This fraction may contribute to evidence of bioactive iron in patients after IV iron administration.